CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT)
May 01, 2018, 12:00 PM
CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT), returns to Stock Day to give details on Precision Oncology, tumor & drug testing, and growing via targeted therapies.